ProUroCare Medical Inc. (OTCPK: PUMD)
Health Care · Health Care Equipment & Supplies · US
$0.00
— today · -50.0% 1Y
ProUroCare Medical Inc. (OTCPK: PUMD) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $1.86K and employs 2 people.
Over the last twelve months the share price has lost 50.0%, trading between 0.00 and 0.01.
Tweenvest scores ProUroCare Medical Inc. across four factors: quality 4/100. Its strongest factor is quality.
PUMD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.86K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.12
- Dividend yield
- —
- Beta (5Y)
- 0.81
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 18.60M
- Employees
- 2
- Next earnings
- —
About ProUroCare Medical Inc.
ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.
- ISIN
- US74373C2061
- Founded
- 1999
- Listed since
- Nov 29, 2022
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.81 | +1.19% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.45 | +0.53% |
| Medtronic plcNYSE: MDT | $119.49B | $93.35 | +1.14% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €163.20 | +1.24% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.